Latest news with #BCCResearch
Yahoo
9 hours ago
- Automotive
- Yahoo
Global Physical Vapor Deposition (PVD) Market to Reach $33.1 Billion by 2029
"PVD Coatings Transform Industries with Sustainability, Advanced Thin-Film Technologies and Rising Demand Across Medical, Solar and Electronics Sectors." BOSTON, June 9, 2025 /PRNewswire/ -- According to the latest study from BCC Research, the "Physical Vapor Deposition (PVD): Global Markets" is projected to grow from $22.8 billion in 2024 to $33.1 billion by the end of 2029 at a compound annual growth rate (CAGR) of 7.7% from 2024 through 2029. The global PVD market is segmented by product type (equipment, material, services), technology (thermal evaporation, sputtering), application (medical devices, photovoltaics, cutting tools, data storage and microelectronics), and region (North America, Europe, Asia-Pacific and the Rest of the World). The report covers market dynamics, regulations, ESG trends, competitive landscape, emerging technologies and company profiles of the 15 leading companies. As developed countries accelerate efforts to reduce CO2 emissions, PVD has emerged as a green coating technology, making the industry safer and more sustainable. Restrictions on hexavalent chromium electroplating in Europe and North America have further increased demand for PVD coatings. Additionally, emerging industries such as solar, wind turbines, and green hydrogen are leveraging PVD to enhance product durability and extend service life. The factors driving the market include: Limitation on the Use of Hexavalent Chromium Plating: Regulations restricting the use of toxic hexavalent chromium plating have increased the demand for PVD as a safer and eco-friendly alternative. Increasing Demand for Decorative Coatings: PVD coatings are widely used in luxury goods, automotive and consumer electronics due to their ability to provide a high-quality, durable, and visually appealing finish. Growth in End-Use Industries: Industries such as medical devices, photovoltaics, cutting tools, and microelectronics are rapidly adopting PVD due to its ability to enhance product performance, longevity and efficiency. Digitalization and Automation in the PVD Market: Technological advancements are improving PVD efficiency, enabling faster production, better precision, and reduced costs through automation. Request a sample copy of The Global Physical Vapor Deposition Market report. Report Synopsis Report Metric Details Base year considered 2023 Forecast period considered 2024-2029 Base year market size $21.5 billion Market size forecast $33.1 billion Growth rate CAGR of 7.7% from 2024 to 2029 Segments covered Product type, technology type, application and region Regions covered North America, Europe, Asia-Pacific, and the Rest of the World (RoW) Market drivers • Limitation on the use of hexavalent chromium plating. • Increasing the demand for decorative coatings. • Growth in end-use industries. • Digitalization and automation in the PVD market. Interesting facts: Leading companies in the PVD market are focusing on the development of cutting-edge technologies, such as high power impulse magnetron sputtering (HiPIMS), dual magnetron sputtering, and hybrid PVD process to improve thin-film coating quality. Changing deposition materials in the PVD industry is driving innovation, helping PVD coating companies sustain themselves in a competitive market. For example, coating materials for cutting tools have shifted from stainless steel to aluminum, titanium, nickel, and composite materials such as plastic and, metal. The report addresses the following questions: What is the market's projected size and growth rate?- The global market for physical vapor deposition was valued at $21.5 billion in 2023 and will reach $33.1 billion by the end of 2029 with a CAGR of 7.7%. What segments are covered in the market?- The market is segmented based on product type, technology type, application, and region. Which technology type segment will dominate the market in 2029?- The sputtering segment will dominate the market in 2029. Which region has the highest share in the market?- Asia-Pacific holds the largest share of the global market. Leading companies include: AJA INTERNATIONAL INC. APPLIED MATERIALS INC. ASMPT IHI CORP. INTEVAC INC. KOBE STEEL LTD. KURT J. LESKER CO. LAM RESEARCH CORP. LEYBOLD OC OERLIKON MANAGEMENT AG PLANSEE SE PLASMA-THERM PLATIT AG SINGULUS TECHNOLOGIES AG ULVAC INC. VEECO INSTRUMENTS INC. Related reports include: High-performance Ceramic Coatings: Global Markets and Technologies: This report segments the global high-performance ceramic coatings market by product type, technology, distribution channel, end use and region. It covers oxide, carbide and nitride coatings, key technologies like thermal spray and PVD, and applications in automotive, aerospace, industrial, energy and medical sectors across North America, Europe, Asia-Pacific and RoW. Global Markets for Roll-to-Roll Technologies for Flexible Devices: This report provides a comprehensive review of roll-to-roll (R2R) technologies for flexible devices, detailing various device types and fabrication processes. It covers the current market status, trends and growth forecasts for the next five years, segmented by process category, substrate material, deposition method, end-use industry and region. The report also highlights key technological developments and market revenues, and it examines trends, challenges, ESG developments, patents and profiles of leading companies in the R2R technologies market. Navigate Uncertainty with Confidence In times of rapid change and uncertainty, having the right insights can make all the difference. At BCC Research, we are here to support innovation and help you stay ahead. Our custom research reports provide a comprehensive, 360-degree view of your market landscape, giving you the clarity you need to make informed decisions. We believe that timely, expert market intelligence should be accessible to all. That is why, for a limited time, we are offering 30% off the price of any BCC Research report to help more organizations gain access to our latest data and insights. Purchase a copy of the report directly from BCC Research. For further information on any of these reports or to make a purchase, contact info@ About BCC Research BCC Research market research reports provide objective, unbiased measurement and assessment of market opportunities. Our experienced industry analysts' goal is to help you make informed business decisions free of noise and hype. Contact Us Corporate HQ: 50 Milk St., Ste. 16, Boston, MA 02109, USAEmail: info@ +1 781-489-7301 For media inquiries, email press@ or visit our media page for access to our market research library. Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. Logo - View original content to download multimedia: SOURCE BCC Research LLC Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 days ago
- Business
- Yahoo
Photonic Integrated Circuits Market Set for 11.8% CAGR Boost, Propelled by Silicon Photonics Innovation '
"Comprehensive Report on Photonic Integrated Circuits (PICs) Market: Advancements, Dynamics and Applications Across Industries; Insights into Innovations, Regulatory Challenges and Market Opportunities" BOSTON, June 5, 2025 /PRNewswire/ -- According to the latest study from BCC Research, the "Photonic Integrated Circuits: Global Markets with Special Focus on Silicon Photonics" is expected to grow from $13.9 billion in 2024 to $24.2 billion by the end of 2029 at a compound annual growth rate (CAGR) of 11.8% from 2024 through 2029. The report provides an in-depth analysis of the photonic integrated circuits (PICs) market, focusing on components such as transceivers, lasers, modulators, detectors, multiplexers/demultiplexers (MUX/DEMUX) and optical amplifiers, assessing their adoption across diverse applications that include optical communication, sensing, biophotonics and optical signal processing. The study consists of a regional analysis covering North America, Europe, Asia-Pacific, and other regions, highlighting market dynamics, trends and innovations. The relevance of this report lies in the significant advancements in the PICs market. Innovations are expanding PIC applications across various industries, driven by the increasing demand for high-speed data transmission in telecommunications, the growing adoption of quantum computing, and the need for miniaturized and energy-efficient solutions in optical systems. Staying updated on these developments is crucial for stakeholders to capitalize on emerging opportunities and maintain a competitive edge in this rapidly evolving landscape. The factors driving the market's growth include: High-Speed Data Transmission: Increasing data consumption from smart devices and IoT requires faster data transmission. PICs, especially silicon photonics, meet these needs with high-speed, low-latency data handling. Energy Efficiency and Sustainability: PICs use light for data transmission, reducing power consumption and heat, making them energy-efficient and aligning with sustainability goals. Device Miniaturization: PICs integrate multiple photonic functions on a single chip, reducing size and complexity, which is essential for compact devices in telecom, medical, and consumer electronics. Sustainability Advances: Sustainability initiatives drive innovations in PICs, leading to efficient manufacturing and materials, reducing environmental impact, and supporting broader sustainability goals. Request a sample copy of report the global market for photonic integrated circuits. Report Synopsis Report Metric Details Base year considered 2023 Forecast period considered 2024-2029 Base year market size $12.5 billion Market size forecast $24.2 billion Growth rate CAGR of 11.8% from 2024 to 2029 Segments covered Component, integration type, raw material, application, and region Regions covered North America, Europe, Asia-Pacific, and the Rest of the World (Latin America the Middle East, and Africa) Market drivers • Rising demand for high-speed data transmission and processing. • Emphasis on enhanced energy efficiency and sustainability. • Expanding requirements for device miniaturization and compact solutions. • Advances through sustainability initiatives. Interesting facts: Advanced PICs, which improve data transmission and processing, are making light-based technologies more efficient than traditional electronic circuits. Combining advanced PICs with new technologies allows for faster data transfer, lower power use, and smaller device sizes, improving telecommunications, quantum computing and high-speed internet performance. PICs are increasingly used in healthcare, automotive and telecommunications because they offer high-speed communication and reliability. This trend shows a shift toward photonic technologies for new applications like self-driving cars, real-time data processing and advanced sensors. Emerging startups: Ephos Lightmatter Salience Labs Ltd. The report addresses the following questions: 1. What is the market's projected size and growth rate? The global PICs market is projected to reach $24.2 billion by the end of 2029, growing at a CAGR of 11.8%. 2. What factors are driving the growth of the market? The key factors driving the market include: Rising demand for high-speed data transmission and processing. Emphasis on enhanced energy efficiency and sustainability. Expanding requirements for device miniaturization and compact solutions. 3. What segments are covered in the report? The report is segmented into component, integration type, raw material, application and region. 4. Which application segment will be dominant in 2029? The Optical datacom application segment is expected to dominate the market by the end of 2029. 5. Which region has the largest market share? North America holds the largest share of the global PICs market. Leading companies include: AYAR LABS BROADEX TECHNOLOGIES CIENA CORP. CISCO SYSTEMS INC. COHERENT CORP. EFFECT PHOTONICS EMCORE CORP. INFINERA CORP. INTEL CORP. LUMENTUM OPERATIONS LLC. POET TECHNOLOGIES INC. POLARITON TECHNOLOGIES AG SCINTIL PHOTONICS SOURCE PHOTONICS SUMITOMO ELECTRIC INDUSTRIES LTD. Related Reports Include: Printed Circuit Boards: Technologies and Global Markets: This report comprehensively analyzes the global printed circuit board (PCB) market, covering data from 2023 and projections through 2029. It details global revenue across five market segments and four regions, examines growth drivers and challenges, and highlights leading PCB manufacturers. Additionally, the report explores emerging technologies, competitive factors and ESG developments within the industry. Fiber Optic Sensors: Global Markets: This report provides an in-depth analysis of various fiber optic sensors, including intrinsic and extrinsic types, and their applications across multiple industries such as defense, energy, and telecommunications. It examines market trends, growth drivers and regional dynamics and includes profiles of leading sensor companies. The report also covers key sensor components and technologies and offers market projections and CAGRs from 2024 to 2029 for North America, Europe, Asia-Pacific, and the Rest of the World. Navigate Uncertainty with Confidence In times of rapid change and uncertainty, having the right insights can make all the difference. At BCC Research, we are here to support innovation and help you stay ahead. Our custom research reports provide a comprehensive, 360-degree view of your market landscape, giving you the clarity you need to make informed decisions. We believe that timely, expert market intelligence should be accessible to all. That is why, for a limited time, we are offering 30% off the price of any BCC Research report to help more organizations gain access to our latest data and insights. Purchase a copy of the report directly from BCC Research. For further information on any of these reports or to make a purchase, contact info@ About BCC Research BCC Research market research reports provide objective, unbiased measurement, and assessment of market opportunities. Our experienced industry analysts' goal is to help you make informed business decisions free of noise and hype. Contact UsCorporate HQ: 50 Milk St., Ste. 16, Boston, MA 02109, USAEmail: info@ +1 781-489-7301 For media inquiries, email press@ or visit our media page for access to our market research library. Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. Logo: View original content to download multimedia: SOURCE BCC Research LLC Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 days ago
- Business
- Yahoo
Nanotechnology in Cancer Treatment Market Positioned for Transformational Growth by 2029
'Explore how nanomedicine and targeted therapies are shaping the future of cancer care in BCC Research's global market analysis of nanotechnology in oncology.' Boston, June 05, 2025 (GLOBE NEWSWIRE) -- As cancer prevalence continues to rise globally, nanotechnology in cancer treatment is emerging as a transformative force in oncology. Leveraging nanoscale drug delivery systems and precision-targeting techniques, companies such as AstraZeneca, F. Hoffmann-La Roche Ltd., and Bristol-Myers Squibb are developing next-generation solutions to enhance therapeutic effectiveness while minimizing harm to healthy cells. According to the report, growing cancer prevalence, rising government funding, and increased pharmaceutical R&D spending are reshaping innovation strategies across the oncology landscape. The global market is projected to grow at a CAGR of 17.4% from 2024 to 2029. As North America continues to lead market expansion and new nanomedicine applications evolve globally, stakeholders must navigate regulatory complexity, manufacturing scalability, and long-term safety considerations to harness the full potential of this technology. Market Overview: Key Insights and Forecast BCC Research's latest report, Nanotechnology in Cancer Treatment: Technologies and Global Markets, delivers a detailed evaluation of the evolving oncology landscape through the lens of nanomedicine. It explores how advances in nanostructured materials, targeted delivery systems, and diagnostic innovations are shaping the future of cancer treatment across major regions. The global market was valued at $102.4 billion in 2023 and is projected to reach $265.4 billion by the end of 2029. The report delivers forward-looking insights based on current market trends and expected developments over the forecast period. It provides a strategic analysis of major segments by product type and cancer type, along with comprehensive coverage of revenue trends, regulatory frameworks, ESG priorities, technological advancements, and regional market shifts. Market Leadership in Transition The cancer nanomedicine space is evolving rapidly, with companies investing in product differentiation and late-stage R&D. Liposomes remain the most commercially established carriers, while polymeric nanoparticles and dendrimers are seeing increased use due to their payload capacity and tumor selectivity (Chapter 6: Market Segment Analysis). Leading companies such as Pfizer, Novartis AG, and Jazz Pharmaceuticals are developing tailored nanocarrier systems for specific cancer indications, with a focus on breast and lung cancers. These therapies are being designed for better tumor penetration, reduced off-target toxicity and improved treatment outcomes (Chapter 7: Competitive Intelligence). Emerging Technologies and Investment Trends Innovation in nanomedicine is being fueled by multifunctional systems that integrate diagnosis, therapy, and monitoring. Technologies including quantum dots, cancer stem cell-targeting particles, and nanorobotics are moving closer to clinical translation, offering new capabilities in image-guided therapy and adaptive dosing. Strong capital inflow and increased partnerships between biotech firms and research institutions are accelerating development across early and mid-stage pipelines. These trends are unlocking commercialization potential, especially in minimally invasive therapies and immuno-nanomedicine (Chapter 5: Emerging Technologies and New Developments). Pipeline Assessment and Applications The oncology pipeline is steadily embracing nanotechnology as a cornerstone for targeted treatment development. Companies are advancing nanoparticle-based drug carriers with enhanced tumor penetration, improved bioavailability and reduced toxicity. These innovations are driving late-stage R&D across different types of cancers, such as breast and lung cancers, leukemia and melanoma. In parallel, there is growing interest in integrating diagnostic and therapeutic functions into single nanosystems. Platforms capable of simultaneous drug delivery and real-time tumor tracking are gaining momentum, offering the potential for adaptive dosing and early relapse detection (Chapter 6: Market Segment Analysis). Regulatory and Access Challenges Regulatory agencies, such as the U.S. FDA, European Medicines Agency (EMA), and other international bodies, are actively evolving frameworks to support the safe and effective approval of nanoscale cancer therapies. As manufacturers scale production, they must comply with stringent requirements related to materials handling, product traceability and lifecycle oversight (Chapter 4: Regulatory Landscape). Challenges such as development costs, access limitations in low-income regions, and a shortage of oncology specialists trained in nanomedicine are slowing down broader adoption. Addressing these issues is essential to achieving long-term growth and equitable global impact (Chapter 3: Market Dynamics). Strategic Outlook: The Road Ahead With nanotechnology's role in oncology continuing to expand, companies are aligning R&D with long-term goals around innovation, clinical efficacy, and accessibility. Key companies are developing platforms that support patient-centered care, data-driven treatment personalization, and integration across diagnostic and therapeutic pathways (Chapter 2: Market Overview). As infrastructure improves and global interest in targeted therapies grows, nanomedicine is expected to become a cornerstone of modern cancer care. Firms prioritizing early diagnosis, adaptive delivery and long-term monitoring will be best positioned to lead the market forward (Chapter 7: Competitive Intelligence). Report Synopsis Report Metric Details Base year considered 2023 Forecast period considered 2024-2029 Base year market size $102.4 billion Market size forecast $265.4 billion Growth rate CAGR of 17.4% for the forecast period of 2024-2029 Segments covered Product type and cancer type Regions covered North America, Europe, Asia-Pacific, South America, Rest of the World Countries covered The U.S., Canada, Mexico, Germany, France, Italy, Spain, the U.K., Austria, Sweden, Denmark, Poland, Turkey, Switzerland, the Netherlands, China, Japan, India, South Korea, Australia, Thailand, Singapore, Malaysia, New Zealand, Vietnam, Brazil, Argentina, Colombia, Paraguay, Peru, Middle East and Africa Market drivers Increasing prevalence of cancer cases globally. Rise in government funding and pharmaceutical R&D spending. Nanoparticles in cancer treatment: Advantages. Precision targeting of cancer cells with nanomaterials. Additional Insights: Ultra-small and highly efficient: Nanoparticles are often smaller than a single cell; thus, it is easier for them to penetrate tumors and deliver drugs directly to cancer cells. Stealth functionality: These particles can be engineered to "cloak" themselves from the immune system, allowing them to circulate longer within the bloodstream. Multifunctional carriers: Nanoparticles can transport multiple drugs simultaneously, enabling combination therapies in a single delivery. Energy-interactive: They can absorb energy from external sources, supporting their role in advanced imaging or therapeutic enhancement. Next-level diagnostics: Nanoparticles can serve as highly sensitive imaging agents, enhancing early diagnosis and treatment precision. Leading companies include: AstraZeneca Baxter Boston Scientific Corp. Bristol-Myers Squibb Co. F. Hoffmann-La Roche Ltd. Jazz Pharmaceuticals Inc. Les Laboratoires Servier Novartis AG Pfizer Inc. Teva Pharmaceutical Industries Ltd. Navigate Uncertainty with ConfidenceIn times of rapid change and uncertainty, having the right insights can make all the difference. At BCC Research, we are here to support innovation and help you stay ahead. Our custom research reports provide a comprehensive, 360-degree view of your market landscape, providing you with the clarity you need to make informed decisions. We believe that timely, expert market intelligence should be accessible to all. That is why, for a limited time, we are offering 30% off the price of any BCC Research report to help more organizations gain access to our latest data and insights. Get your copy of the report directly from BCC Research. To request more information or complete your purchase, connect with us at info@ About BCC Research BCC Research market research reports provide objective, unbiased measurement and assessment of market opportunities. Our experienced industry analysts' goal is to help you make informed business decisions free of noise and hype. For media inquiries, email press@ or visit our media page for access to our market research library. Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. CONTACT: BCC Research Corporate HQ: 50 Milk St., Ste. 16, Boston, MA 02109, USA Email: info@ Phone: +1 781-489-7301
Yahoo
5 days ago
- Business
- Yahoo
Global Colorectal Cancer Screening and Diagnostics Market to Reach $46.1 Billion by 2029
"Rising Colorectal Cancer Incidence and Demand for Early, Non-Invasive Diagnostics Propel Global Market Growth Across Test Types, End Users and Regions" BOSTON, June 4, 2025 /PRNewswire/ -- According to the latest study from BCC Research, "Global Colorectal Cancer Screening and Diagnostics Market" is projected to grow from $40.0 billion in 2024 to $46.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 2.9% from 2024 through 2029. The report provides a detailed overview including market trends, dynamics, and emerging technologies. It highlights drivers, challenges, and opportunities within the industry and features comprehensive profiles of leading manufacturers and service providers such as Fujifilm Holdings Corporation, Olympus Corporation, Exact Sciences Corporation, Danaher Corporation, Guardant Health, New Horizon Health, and Quest Diagnostics. The report offers market projections and application forecasts for the next five years and analyze major companies' financials, product portfolios and recent activities. The factors driving the market's growth include: Increasing Incidence of Colorectal Cancer: More people are being diagnosed with colorectal cancer, especially younger adults, due to lifestyle and genetic factors. Growing Financial Burden: The high costs of treatment and care for colorectal cancer drive the need for cost-effective screening and diagnostics. Advances in Genomics and Molecular Diagnostics: New technologies in genomics are improving the accuracy and personalization of colorectal cancer diagnostics. Rise in Demand for Non-Invasive Screening: Non-invasive tests like stool and blood tests are becoming more popular, making screening easier and more accessible. Need for Early Detection: Early detection of colorectal cancer reduces treatment costs and improves survival rates, pushing the adoption of advanced screening technologies. Request a sample copy of the global colorectal cancer screening and diagnostic testing service market report. Report Synopsis Report Metric Details Base year considered 2023 Forecast period considered 2024-2029 Base year market size $39.0 billion Market size forecast $46.1 billion Growth rate CAGR of 2.9% for the forecast period of 2024-2029 Segments covered Test type, end-use industry and region Regions covered North America, Europe, Asia-Pacific and Rest of the World (RoW) Countries covered The U.S., Canada, Mexico, Germany, France, Italy, Spain, the U.K., the Netherlands, Poland, the Czech Republic, Hungary, Austria, Slovakia, Slovenia, China, India, Japan, South Korea, Australia, Thailand, Singapore, Vietnam, South America, Middle East and Africa Market drivers • Increasing incidence of colorectal cancer. • High treatment cost. • Advances in genomics and molecular diagnostics. • Rise in demand for non-invasive colorectal cancer screening. • Growing need for early cancer detection to lower treatment costs. Interesting facts: At-home stool-based tests, such as FIT and Cologuard, are gaining popularity for their convenience and effectiveness, boosting screening compliance rates. Treating late-stage colorectal cancer can cost up to three times more than early-stage treatment, emphasizing the economic benefits of widespread screening programs. In early trials, artificial intelligence has shown the ability to detect cancers, such as colorectal cancer, with accuracy rates comparable to or even better than those of human radiologists. Emerging startups: Freenome Holdings, Inc. GI-View Geneoscopy, Inc. AcuamarkDx. The report addresses the following questions: What is the market's projected size and growth rate?- The colorectal cancer screening and diagnostic testing service market is projected to grow from $39.0 billion in 2023 to $46.1 billion in 2029 at a CAGR of 2.9% during the forecast period. What are the key factors driving the growth of the market?- The increasing incidence of colorectal cancer.- The upsurge in the financial burden on healthcare associated with colorectal cancer.- Advancements in genomics and molecular diagnostics.- The rise in demand for non-invasive colorectal cancer screening.- The growing need for early cancer detection to lower treatment costs. What market segments are covered in the report?- The market is segmented based on test type, end user, and region. Which segment will dominate the market by the end of 2029?- The colonoscopy and sigmoidoscopy test type segment will dominate the market by the end of 2029. Which region has the largest market share?- North America holds the largest share of the global market. Leading companies include: EXACT SCIENCES CORP. DANAHER CORP. DIACARTA EIKEN CHEMICAL CO. LTD. FREENOME HOLDINGS INC. FUJIFILM HOLDINGS CORP. GI-VIEW GUARDANT HEALTH HANGZHOU NOVAHEALTH TECHNOLOGY CO. LTD. LABORATORY CORPORATION OF AMERICA HOLDINGS LEPU MEDICAL TECHNOLOGY (BEIJING) CO. LTD. MAINZ BIOMED N.V. NOVIGENIX SA OLYMPUS CORP. QUEST DIAGNOSTICS INC. QUIDELORTHO CORP. Related Reports Include: Routine Health Screening Market: The routine health screening market is rapidly expanding due to the increasing focus on preventive healthcare and the rising incidence of non-communicable diseases like diabetes and cardiovascular disorders. Technological advancements, such as AI integration in diagnostic tools, have improved the accuracy and accessibility of screenings. The COVID-19 pandemic has highlighted the importance of regular health check-ups, further boosting the market. Additionally, the incorporation of screenings into corporate wellness programs and the trend toward personalized medicine drive growth. This market will be crucial in global proactive and personalized health management. Navigate Uncertainty with Confidence In times of rapid change and uncertainty, having the right insights can make all the difference. At BCC Research, we are here to support innovation and help you stay ahead. Our custom research reports provide a comprehensive, 360-degree view of your market landscape, giving you the clarity you need to make informed decisions. We believe that timely, expert market intelligence should be accessible to all. That is why, for a limited time, we are offering 30% off the price of any BCC Research report to help more organizations gain access to our latest data and insights. Purchase a copy of the report directly from BCC Research. For further information on any of these reports or to make a purchase, contact info@ About BCC Research BCC Research market research reports provide objective, unbiased measurement, and assessment of market opportunities. Our experienced industry analysts' goal is to help you make informed business decisions free of noise and hype. Contact Us Corporate HQ: 50 Milk St., Ste. 16, Boston, MA 02109, USAEmail: info@ +1 781-489-7301 For media inquiries, email press@ or visit our media page for access to our market research library. Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. Logo - View original content to download multimedia: SOURCE BCC Research LLC Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 days ago
- Business
- Yahoo
Global Colorectal Cancer Screening and Diagnostics Market to Reach $46.1 Billion by 2029
"Rising Colorectal Cancer Incidence and Demand for Early, Non-Invasive Diagnostics Propel Global Market Growth Across Test Types, End Users and Regions" BOSTON, June 4, 2025 /PRNewswire/ -- According to the latest study from BCC Research, "Global Colorectal Cancer Screening and Diagnostics Market" is projected to grow from $40.0 billion in 2024 to $46.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 2.9% from 2024 through 2029. The report provides a detailed overview including market trends, dynamics, and emerging technologies. It highlights drivers, challenges, and opportunities within the industry and features comprehensive profiles of leading manufacturers and service providers such as Fujifilm Holdings Corporation, Olympus Corporation, Exact Sciences Corporation, Danaher Corporation, Guardant Health, New Horizon Health, and Quest Diagnostics. The report offers market projections and application forecasts for the next five years and analyze major companies' financials, product portfolios and recent activities. The factors driving the market's growth include: Increasing Incidence of Colorectal Cancer: More people are being diagnosed with colorectal cancer, especially younger adults, due to lifestyle and genetic factors. Growing Financial Burden: The high costs of treatment and care for colorectal cancer drive the need for cost-effective screening and diagnostics. Advances in Genomics and Molecular Diagnostics: New technologies in genomics are improving the accuracy and personalization of colorectal cancer diagnostics. Rise in Demand for Non-Invasive Screening: Non-invasive tests like stool and blood tests are becoming more popular, making screening easier and more accessible. Need for Early Detection: Early detection of colorectal cancer reduces treatment costs and improves survival rates, pushing the adoption of advanced screening technologies. Request a sample copy of the global colorectal cancer screening and diagnostic testing service market report. Report Synopsis Report Metric Details Base year considered 2023 Forecast period considered 2024-2029 Base year market size $39.0 billion Market size forecast $46.1 billion Growth rate CAGR of 2.9% for the forecast period of 2024-2029 Segments covered Test type, end-use industry and region Regions covered North America, Europe, Asia-Pacific and Rest of the World (RoW) Countries covered The U.S., Canada, Mexico, Germany, France, Italy, Spain, the U.K., the Netherlands, Poland, the Czech Republic, Hungary, Austria, Slovakia, Slovenia, China, India, Japan, South Korea, Australia, Thailand, Singapore, Vietnam, South America, Middle East and Africa Market drivers • Increasing incidence of colorectal cancer. • High treatment cost. • Advances in genomics and molecular diagnostics. • Rise in demand for non-invasive colorectal cancer screening. • Growing need for early cancer detection to lower treatment costs. Interesting facts: At-home stool-based tests, such as FIT and Cologuard, are gaining popularity for their convenience and effectiveness, boosting screening compliance rates. Treating late-stage colorectal cancer can cost up to three times more than early-stage treatment, emphasizing the economic benefits of widespread screening programs. In early trials, artificial intelligence has shown the ability to detect cancers, such as colorectal cancer, with accuracy rates comparable to or even better than those of human radiologists. Emerging startups: Freenome Holdings, Inc. GI-View Geneoscopy, Inc. AcuamarkDx. The report addresses the following questions: What is the market's projected size and growth rate?- The colorectal cancer screening and diagnostic testing service market is projected to grow from $39.0 billion in 2023 to $46.1 billion in 2029 at a CAGR of 2.9% during the forecast period. What are the key factors driving the growth of the market?- The increasing incidence of colorectal cancer.- The upsurge in the financial burden on healthcare associated with colorectal cancer.- Advancements in genomics and molecular diagnostics.- The rise in demand for non-invasive colorectal cancer screening.- The growing need for early cancer detection to lower treatment costs. What market segments are covered in the report?- The market is segmented based on test type, end user, and region. Which segment will dominate the market by the end of 2029?- The colonoscopy and sigmoidoscopy test type segment will dominate the market by the end of 2029. Which region has the largest market share?- North America holds the largest share of the global market. Leading companies include: EXACT SCIENCES CORP. DANAHER CORP. DIACARTA EIKEN CHEMICAL CO. LTD. FREENOME HOLDINGS INC. FUJIFILM HOLDINGS CORP. GI-VIEW GUARDANT HEALTH HANGZHOU NOVAHEALTH TECHNOLOGY CO. LTD. LABORATORY CORPORATION OF AMERICA HOLDINGS LEPU MEDICAL TECHNOLOGY (BEIJING) CO. LTD. MAINZ BIOMED N.V. NOVIGENIX SA OLYMPUS CORP. QUEST DIAGNOSTICS INC. QUIDELORTHO CORP. Related Reports Include: Routine Health Screening Market: The routine health screening market is rapidly expanding due to the increasing focus on preventive healthcare and the rising incidence of non-communicable diseases like diabetes and cardiovascular disorders. Technological advancements, such as AI integration in diagnostic tools, have improved the accuracy and accessibility of screenings. The COVID-19 pandemic has highlighted the importance of regular health check-ups, further boosting the market. Additionally, the incorporation of screenings into corporate wellness programs and the trend toward personalized medicine drive growth. This market will be crucial in global proactive and personalized health management. Navigate Uncertainty with Confidence In times of rapid change and uncertainty, having the right insights can make all the difference. At BCC Research, we are here to support innovation and help you stay ahead. Our custom research reports provide a comprehensive, 360-degree view of your market landscape, giving you the clarity you need to make informed decisions. We believe that timely, expert market intelligence should be accessible to all. That is why, for a limited time, we are offering 30% off the price of any BCC Research report to help more organizations gain access to our latest data and insights. Purchase a copy of the report directly from BCC Research. For further information on any of these reports or to make a purchase, contact info@ About BCC Research BCC Research market research reports provide objective, unbiased measurement, and assessment of market opportunities. Our experienced industry analysts' goal is to help you make informed business decisions free of noise and hype. Contact Us Corporate HQ: 50 Milk St., Ste. 16, Boston, MA 02109, USAEmail: info@ +1 781-489-7301 For media inquiries, email press@ or visit our media page for access to our market research library. Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. Logo - View original content to download multimedia: SOURCE BCC Research LLC Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
